Related Experiment Video
Updated: May 3, 2026
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective
Cipriano R Gama1, Andre S Franco1, Adriana B Bortoluzzo2
1C.R. Gama, MD, A.S. Franco, MD, R. Miossi, MD, PhD, A.C. Medeiros-Ribeiro, MD, PhD, A.P. Luppino Assad, MD, PhD, P.D. Sampaio-Barros, MD, PhD, Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo.
Objective:
Systemic sclerosis (SSc) often presents alongside other connective tissue disorders, termed "overlap syndrome (OS)." This study aimed to characterize patients with SSc with OS compared to those without OS in a tertiary university hospital in Brazil.
Methods:
A retrospective analysis of demographic, clinical, and laboratory data from 787 SSc patients was performed using electronic medical records. Patients were classified based on the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc and additional criteria for systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM), Sjögren disease (SjD), and rheumatoid arthritis (RA). Statistical analysis, including univariate and multivariate methods, identified factors associated with OS.
Results:
Ninety-one patients (11.6%) had OS, mainly with SLE (29.7%), SjD (26.4%), RA (24.2%), or IIM (19.8%). Patients with OS were younger, with an earlier age at onset (P = 0.004) and at diagnosis (P = 0.003). They presented a higher prevalence of limited SSc (P trend = 0.06), musculoskeletal symptoms (P < 0.001), neoplasia (P = 0.03), and sicca symptoms (P < 0.001); and were associated with a lower frequency of pulmonary hypertension (P = 0.048) and comorbidities such as diabetes mellitus (P = 0.02) and dyslipidemia (P = 0.02). A higher prevalence of anti-Ro (P = 0.007) and a lower prevalence of anti-Scl70 (P = 0.003) were also observed. Patients with OS were more frequently prescribed glucocorticoids (GCs; P < 0.001), methotrexate (P = 0.01), and leflunomide (P = 0.001). Multivariate analysis identified limited SSc (odds ratio [OR] 3.1), neoplasia (OR 3.4), and use of GCs (OR 8.2) and leflunomide (OR 5.5) with OS. No worse prognosis was observed.
Conclusion:
Overall, Brazilian patients with SSc with OS have distinct clinical characteristics but do not have a worse prognosis compared to those without OS.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: